CliffBio
small molecule

BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

SODIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameBACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Active ingredientSODIUM CHLORIDE
Strength270MG/30ML (9MG/ML)
Dosage formSOLUTION
RouteINJECTION
ModalitySmall molecule
FDA approvalFebruary 1985
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.